LCK and B-cell chronic lymphocytic leukemia: Considering that inhibition of Lck (with Lck-i) and of PI3Kδ (with idelalisib) produce mechanistically similar effects, determination of Lck expression in ZAP70 + CLL cases may be useful for patient stratification strategies to receive idelalisib.